Publication | Closed Access

Efficacy of protracted dose-dense temozolomide in patients with recurrent high-grade glioma

Neuro-oncologyRadiation TherapyMedicineMetronomic TherapyRecurrent High-grade GliomaNeurologyHigh-grade GliomasCancer TreatmentRadiation OncologyOncologyGliomaProtracted Dose-dense Temozolomide